Objective To investigate the effects of DMOG on the microcirculation of the choke-area and the survival of the cross-boundary flap in rats via tail vein injection. Methods Rats with ischemic three-territory perforator flaps on the dorsum were treated with DMOG at a dosage of 40 mg/kg body weight via tail vein injection at 1 day before surgery (day-1) , the time of surgery (day 0) , 1 day after surgery (day 1) , 2 days after surgery (day 2) and 3 days after surgery (day 3). Control group received sterile saline at the same time points and same dosage via tail vein injection. ① Draw materials from the choke-area at day 1, day 3 and day 7, HE stain was used to compare the diameter size of the artery and vein at the same site. ② Western blotting to check the expression of PCNA and HIF-1α, ELISA to detect the content of PCNA, HIF-1α, SDF-1α and VEGF at day 7. ③At day 7, measure the survival area of the flap and observe the vessel of the flap by lead oxide-gelatine technique. Results ① There was a greater survival rate of (96.3 ± 5.1) % in the treatment group than in the control group with (73.9 ± 5.8) % at day 7 (P < 0.05). ② The diameter size of the arterioles and venules were dilated in both groups until postoperative days 7. But the treatment group was more expanded than the control group at day 3 (2.20 ± 0.26 vs.1.50 ± 0.20, P < 0.05) and day 7 (3.67 ± 0.35 vs. 2.03 ± 0.15, P < 0.05). ③ The skin expression of PCNA and HIF-1α in the treatment group were greater than the control group (P < 0.05) at day 7. ④ The content of skin PCNA in the treatment group and control group were (8.95 ± 0.71) ng/mg and (4.15 ± 0.72) ng/mg, HIF-1α were (5.04 ± 0.50) ng/mg and (2.98 ± 0.29) ng/mg, SDF-1α were (2.91 ± 0.61) ng/mg and (1.39 ± 0.62) ng/mg, and VEGF were (2.17 ± 0.41) ng/mg and (0.95 ± 0.44) ng/mg, respectively. The treatment group was greater than the control group (P < 0.05). Conclusion DMOG can improve the microcirculation of the choke area, and then increase the survival of the perforator skin flaps in rats via tail vein injection. Key words: Dimethyloxalylglycine; Choke vessels; Cross-boundary flap; Perforator flap; Hemodynamics
Read full abstract